Expression of the podocyte marker gene podocin (NPHS2) varied but was highest on the first day of observation in patients with ischemic AKI (Fig. 1B) and increased by the fifth day in those with toxic AKI (Fig. 1D). The gene discussed is NPHS2; the disease is acute kidney injury.